[1] |
FIELDING RA, VELLAS B, EVANS WJ, et al. Sarcopenia: An undiagnosed condition in older adults. Current consensus definition: Prevalence, etiology, and consequences. International working group on sarcopenia[J]. J Am Med Dir Assoc, 2011, 12(4): 249-256. DOI: 10.1016/j.jamda.2011.01.003.
|
[2] |
VURAL A, ATTAWAY A, WELCH N, et al. Skeletal muscle loss phenotype in cirrhosis: A nationwide analysis of hospitalized patients[J]. Clin Nutr, 2020, 39(12): 3711-3720. DOI: 10.1016/j.clnu.2020.03.032.
|
[3] |
YANG QQ, SUN Y. Research progress on molecular mechanism of skeletal muscle mass reduction in sarcopenia[J]. J Clin Exp Med, 2020, 19(9): 1006-1009. DOI: 10.3969/j.issn.1671-4695.2020.09.032.
杨琦琦, 孙颖. 肌少症中骨骼肌质量减少的分子机制研究进展[J]. 临床和实验医学杂志, 2020, 19(9): 1006-1009. DOI: 10.3969/j.issn.1671-4695.2020.09.032.
|
[4] |
WILLIAMS FR, BERZIGOTTI A, LORD JM, et al. Review article: Impact of exercise on physical frailty in patients with chronic liver disease[J]. Aliment Pharmacol Ther, 2019, 50(9): 988-1000. DOI: 10.1111/apt.15491.
|
[5] |
ROSENBERG IH. Sarcopenia: Origins and clinical relevance[J]. Clin Geriatr Med, 2011, 27(3): 337-339. DOI: 10.1016/j.cger.2011.03.003.
|
[6] |
CRUZ-JENTOFT AJ, BAEYENS JP, BAUER JM, et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People[J]. Age Ageing, 2010, 39(4): 412-423. DOI: 10.1093/ageing/afq034.
|
[7] |
FIELDING RA, VELLAS B, EVANS WJ, et al. Sarcopenia: An undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia[J]. J Am Med Dir Assoc, 2011, 12(4): 249-256. DOI: 10.1016/j.jamda.2011.01.003.
|
[8] |
MONTANO-LOZA AJ, MEZA-JUNCO J, PRADO CM, et al. Muscle wasting is associated with mortality in patients with cirrhosis[J]. Clin Gastroenterol Hepatol, 2012, 10(2): 166-173, 173.e1. DOI: 10.1016/j.cgh.2011.08.028.
|
[9] |
MONTANO-LOZA AJ, DUARTE-ROJO A, MEZA-JUNCO J, et al. Inclusion of sarcopenia within MELD (MELD-Sarcopenia) and the prediction of mortality in patients with cirrhosis[J]. Clin Transl Gastroenterol, 2015, 6(7): e102. DOI: 10.1038/ctg.2015.31.
|
[10] |
NARDELLI S, LATTANZI B, TORRISI S, et al. Sarcopenia is risk factor for development of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt placement[J]. Clin Gastroenterol Hepatol, 2017, 15(6): 934-936. DOI: 10.1016/j.cgh.2016.10.028.
|
[11] |
LATTANZI B, GIOIA S, DI COLA S, et al. Prevalence and impact of sarcopenia in non-cirrhotic portal hypertension[J]. Liver Int, 2019, 39(10): 1937-1942. DOI: 10.1111/liv.14160.
|
[12] |
CAREY EJ, LAI JC, WANG CW, et al. A multicenter study to define sarcopenia in patients with end-stage liver disease[J]. Liver Transpl, 2017, 23(5): 625-633. DOI: 10.1002/lt.24750.
|
[13] |
TANDON P, NEY M, IRWIN I, et al. Severe muscle depletion in patients on the liver transplant wait list: Its prevalence and independent prognostic value[J]. Liver Transpl, 2012, 18(10): 1209-1216. DOI: 10.1002/lt.23495.
|
[14] |
LIU J, HUANG H. Pathogenesis and current status of diagnosis and treatment of cirrhotic sarcopenia[J]. J Clin Hepatol, 2020, 36(4): 895-899. DOI: 10.3969/j.issn.1001-5256.2020.04.041.
刘嘉, 黄华. 肝硬化肌肉减少症的发病机制及诊治现状[J]. 临床肝胆病杂志, 2020, 36(4): 895-899. DOI: 10.3969/j.issn.1001-5256.2020.04.041.
|
[15] |
DENT E, MORLEY JE, CRUZ-JENTOFT AJ, et al. International Clinical Practice Guidelines for Sarcopenia (ICFSR): Screening, diagnosis and management[J]. J Nutr Health Aging, 2018, 22(10): 1148-1161. DOI: 10.1007/s12603-018-1139-9.
|
[16] |
WEBBORN JAD. ACSM's exercise management for persons with chronic diseases and disabilities[J]. Br J Sports Med, 1997, 31(4): 354. DOI: 10.1136/bjsm.31.4.354-b.
|
[17] |
CHEN HW, DUNN MA. Arresting frailty and sarcopenia in cirrhosis: Future prospects[J]. Clin Liver Dis (Hoboken), 2018, 11(2): 52-57. DOI: 10.1002/cld.691.
|
[18] |
European Association for the Study of the Liver. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis[J]. J Hepatol, 2018, 69(2): 406-460. DOI: 10.1016/j.jhep.2018.03.024.
|
[19] |
European Association for Study of Liver; Asociacion Latinoamericana para el Estudio del Higado. EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis[J]. J Hepatol, 2015, 63(1): 237-264. DOI: 10.1016/j.jhep.2015.04.006.
|
[20] |
SARIN SK, KUMAR M, LAU GK, et al. Asian-Pacific clinical practice guidelines on the management of hepatitis B: A 2015 update[J]. Hepatol Int, 2016, 10(1): 1-98. DOI: 10.1007/s12072-015-9675-4.
|
[21] |
PILLARD F, LAOUDJ-CHENIVESSE D, CARNAC G, et al. Physical activity and sarcopenia[J]. Clin Geriatr Med, 2011, 27(3): 449-470. DOI: 10.1016/j.cger.2011.03.009.
|
[22] |
BACURAU AV, JANNIG PR, de MORAES WM, et al. Akt/mTOR pathway contributes to skeletal muscle anti-atrophic effect of aerobic exercise training in heart failure mice[J]. Int J Cardiol, 2016, 214: 137-147. DOI: 10.1016/j.ijcard.2016.03.071.
|
[23] |
FAUSTINI-PEREIRA JL, HOMERCHER-GALANT L, GARCIA E, et al. Exercise capacity of cirrhotic patients with hepatopulmonary syndrome[J]. Ann Hepatol, 2015, 14(3): 361-368.
|
[24] |
ZENITH L, MEENA N, RAMADI A, et al. Eight weeks of exercise training increases aerobic capacity and muscle mass and reduces fatigue in patients with cirrhosis[J]. Clin Gastroenterol Hepatol, 2014, 12(11): 1920-1926.e2. DOI: 10.1016/j.cgh.2014.04.016.
|
[25] |
KERLING A, HARTUNG D, STUBBS B, et al. Impact of aerobic exercise on muscle mass in patients with major depressive disorder: A randomized controlled trial[J]. Neuropsychiatr Dis Treat, 2018, 14: 1969-1974. DOI: 10.2147/NDT.S167786.
|
[26] |
XIANG Q, CHEN X, TAN GX, et al. Clinical observation of low-intensity exercise in patients with liver cirrhosis[J]. West China Med J, 2017, 32(9): 1370-1374. DOI: 10.7507/1002-0179.201606031.
向谦, 陈霞, 谭光秀, 等. 肝硬化患者低强度运动临床观察[J]. 华西医学, 2017, 32(9): 1370-1374. DOI: 10.7507/1002-0179.201606031.
|
[27] |
AAMANN L, DAM G, BORRE M, et al. Resistance training increases muscle strength and muscle size in patients with liver cirrhosis[J]. Clin Gastroenterol Hepatol, 2020, 18(5): 1179-1187.e6. DOI: 10.1016/j.cgh.2019.07.058.
|
[28] |
DEBETTE-GRATIEN M, TABOURET T, ANTONINI MT, et al. Personalized adapted physical activity before liver transplantation: Acceptability and results[J]. Transplantation, 2015, 99(1): 145-150. DOI: 10.1097/TP.0000000000000245.
|
[29] |
PALOP MONTORO MV, PÁRRAGA MONTILLA JA, LOZANO AGUILERA E, et al. Sarcopenia intervention with progressive resistance training and protein nutritional supplements[J]. Nutr Hosp, 2015, 31(4): 1481-1490. DOI: 10.3305/nh.2015.31.4.8489.
|
[30] |
DONG X, WANG XQ, WANG XH, et al. Research progress on molecular mechanism of skeletal muscle mass reduction in sarcopenia[J]. Chin J Gerontol, 2022, 42(3): 744-748. DOI: 10.3969/j.issn.1671-4695.2020.09.032.
董欣, 王小清, 王秀华, 等. 氧化应激在肌少症发生过程中作用的研究进展[J]. 中国老年学杂志, 2022, 42(3): 744-748. DOI: 10.3969/j.issn.1671-4695.2020.09.032.
|
[31] |
SUMMERMATTER S, THURNHEER R, SANTOS G, et al. Remodeling of calcium handling in skeletal muscle through PGC-1α: Impact on force, fatigability, and fiber type[J]. Am J Physiol Cell Physiol, 2012, 302(1): C88-C99. DOI: 10.1152/ajpcell.00190.2011.
|
[32] |
PADRÃO AI, FIGUEIRA AC, FAUSTINO-ROCHA AI, et al. Long-term exercise training prevents mammary tumorigenesis-induced muscle wasting in rats through the regulation of TWEAK signalling[J]. Acta Physiol (Oxf), 2017, 219(4): 803-813. DOI: 10.1111/apha.12721.
|
[33] |
PIN F, BUSQUETS S, TOLEDO M, et al. Combination of exercise training and erythropoietin prevents cancer-induced muscle alterations[J]. Oncotarget, 2015, 6(41): 43202-43215. DOI: 10.18632/oncotarget.6439.
|
[34] |
ELKINA Y, von HAEHLING S, ANKER SD, et al. The role of myostatin in muscle wasting: An overview[J]. J Cachexia Sarcopenia Muscle, 2011, 2(3): 143-151. DOI: 10.1007/s13539-011-0035-5.
|
[35] |
YARASHESKI KE, BHASIN S, SINHA-HIKIM I, et al. Serum myostatin-immunoreactive protein is increased in 60-92 year old women and men with muscle wasting[J]. J Nutr Health Aging, 2002, 6(5): 343-348. http://www.researchgate.net/profile/Kevin_Yarasheski/publication/10998041_Serum_myostatin-immunoreactive_protein_is_increased_in_60-92_year_old_women_and_men_with_muscle_wasting/links/547c9b8c0cf27ed9786229f7/Serum-myostatin-immunoreactive-protein-is-increased-in-60-92-year-old-women-and-men-with-muscle-wasting.pdf
|
[36] |
LENK K, ERBS S, HÖLLRIEGEL R, et al. Exercise training leads to a reduction of elevated myostatin levels in patients with chronic heart failure[J]. Eur J Prev Cardiol, 2012, 19(3): 404-411. DOI: 10.1177/1741826711402735.
|
[37] |
KABAK B, BELVIRANLI M, OKUDAN N. Irisin and myostatin responses to acute high-intensity interval exercise in humans[J]. Horm Mol Biol Clin Investig, 2018, 35(3). DOI: 10.1515/hmbci-2018-0008.
|
[38] |
KONOPKA AR, WOLFF CA, SUER MK, et al. Relationship between intermuscular adipose tissue infiltration and myostatin before and after aerobic exercise training[J]. Am J Physiol Regul Integr Comp Physiol, 2018, 315(3): R461-R468. DOI: 10.1152/ajpregu.00030.2018.
|
[39] |
BUDUI SL, ROSSI AP, ZAMBONI M. The pathogenetic bases of sarcopenia[J]. Clin Cases Miner Bone Metab, 2015, 12(1): 22-26. DOI: 10.11138/ccmbm/2015.12.1.022.
|
[40] |
GIELEN S, ADAMS V, MÖBIUS-WINKLER S, et al. Anti-inflammatory effects of exercise training in the skeletal muscle of patients with chronic heart failure[J]. J Am Coll Cardiol, 2003, 42(5): 861-868. DOI: 10.1016/s0735-1097(03)00848-9.
|
[41] |
EFFTING PS, BRESCIANINI S, SORATO HR, et al. Resistance exercise modulates oxidative stress parameters and TNF-α content in the heart of mice with diet-induced obesity[J]. Arq Bras Cardiol, 2019, 112(5): 545-552. DOI: 10.5935/abc.20190072.
|
[42] |
CUNHA TF, BECHARA LR, BACURAU AV, et al. Exercise training decreases NADPH oxidase activity and restores skeletal muscle mass in heart failure rats[J]. J Appl Physiol (1985), 2017, 122(4): 817-827. DOI: 10.1152/japplphysiol.00182.2016.
|
[43] |
PETROVSKI G, DAS DK. Does autophagy take a front seat in lifespan extension?[J]. J Cell Mol Med, 2010, 14(11): 2543-2551. DOI: 10.1111/j.1582-4934.2010.01196.x.
|
[44] |
GELINO S, HANSEN M. Autophagy-an emerging anti-aging mechanism[J]. J Clin Exp Pathol, 2012, Suppl 4: 006. DOI: 10.4172/2161-0681.s4-006.
|
[45] |
MOREIRA OC, ESTÉBANEZ B, MARTÍNEZ-FLOREZ S, et al. Mitochondrial function and mitophagy in the elderly: Effects of exercise[J]. Oxid Med Cell Longev, 2017, 2017: 2012798. DOI: 10.1155/2017/2012798.
|
[46] |
WHITE Z, TERRILL J, WHITE RB, et al. Voluntary resistance wheel exercise from mid-life prevents sarcopenia and increases markers of mitochondrial function and autophagy in muscles of old male and female C57BL/6J mice[J]. Skelet Muscle, 2016, 6(1): 45. DOI: 10.1186/s13395-016-0117-3.
|
[47] |
MACKENZIE MG, HAMILTON DL, MURRAY JT, et al. mVps34 is activated by an acute bout of resistance exercise[J]. Biochem Soc Trans, 2007, 35(Pt 5): 1314-1316. DOI: 10.1042/BST0351314.
|